Effect of Gonadotropin-releasing hormone analogue( GnRh-a ) for in vitro fertillization cycles (IVF)

Phase 2

• Conditions: oninflammatory disorders of female genitalia tract.; Complication associated with artificial fertilization, unspecified; N98.9

• Registration Number: IRCT20160722029027N7
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Women aged 20-40 years normal respondering in IVF cycles
Body mass index between 20-30
Fresh embryo transfer cycles
Serum FSH of third menstrual day below 10 and absence of low ovarian response according bologna criteria

Exclusion Criteria

Failed fertilization
Sever endometriosis
Decreased ovarian reserve.
Unwillingness to continue
Absence of good quality embryo
Ovarian stimulation hyper stimulation (more than 18 mature follicles during ovarian stimulation )

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal Ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum ßHcG test.;OOcyte number. Timepoint: After ovarian puncture. Method of measurement: Evaluation with reproductive biologist after ovarian puncture.

Secondary Outcome Measures

Name	Time	Method
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion rate. Timepoint: Loss of pregnancy before 20 weeks. Method of measurement: Ultrasonography.